Italy: Big Pharma to disclose public funding for R&D costs

Amid growing clamour for transparency from the pharmaceutical industry, Italy has become the 1st country to require drug makers to disclose data about public funding for any of their medicines during negotiations over pricing and reimbursement. In the UK, naloxone would be a case in point.